Published recently in JAMA https://jamanetwork.com/journals/jamaneurology/fullarticle/2687472 Yale’s Ziba Kashef reported “researchers have tested a new method for directly measuring synaptic loss in […]
BioHaven Pharmaceuticals announced the outcome from a focused analysis of the topline co-primary and key secondary data from its Phase […]
Eumentis Therapeutics announced the closing of its $3.9 million Series A financing. Proceeds from the financing will be used to […]
CORAL GABLES, Fla., Oct. 19, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
EIP Pharma announced positive results from the Phase 2 AscenD-LB study in patients with mild-to-moderate dementia with Lewy bodies (DLB). […]
CORAL GABLES, Fla., Oct. 06, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]
Neurotherapia announced the closing of its Series A financing for $8.8M. The Series A round was led by Brain Trust Accelerator […]
Marinus Pharmaceuticals announced positive results from the phase 3 MARIGOLD study, which evaluated oral ganaxolone in children and young adults […]
Pittsburgh, Aug. 27, 2020 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., a clinical stage neuroscience company developing drugs that treat neurodegenerative […]
CORAL GABLES, Fla., Aug. 06, 2020 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused […]